ArticleJournal for immunotherapy of cancer2025

rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in patients with advanced cancer treated with anti-PD-1/PD-L1 therapy.

Giovanna Polcaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.